The Field Medical Vision
Built to Solve What Others Can’t
Field Medical is advancing a next-generation PFA platform engineered for the most demanding myocardial substrates and designed to scale across arrhythmias.
The Unmet Need
VT remains one of the most complex challenges in catheter ablation. Irregular myocardial substrate, depth variability and procedural instability make consistent lesion formation difficult to achieve with existing technologies. Despite advances in atrial ablation, durable solutions for VT remain limited.
Why We Exist
Field Medical was created to address these limitations directly, not through incremental improvements, but through a fundamentally different approach to energy delivery and system design.
While much of the industry has focused on atrial applications, Field focused first on the ventricle, where success is hardest to achieve and where new approaches are required.
Next-Generation PFA
Next-generation PFA did not exist five years ago. Field Medical was founded on the belief that solving ventricular arrhythmias required a fundamentally different approach — one designed for depth, versatility and control in complex myocardial substrate.
That insight shaped the platform from the ground up.
Our Approach
We focus first where performance is hardest to achieve. By designing for complex ventricular myocardium, the platform is built to deliver consistency, control and depth in the most demanding cases. We’ve created a physician-first foundation for expansion across arrhythmias.
Clinical and Regulatory Momentum
-
First-in-human clinical data in VT published in Circulation
-
Breakthrough Device Designation from the FDA
-
Accepted into the FDA TAP Pilot Program (Total Product Life Cycle Advisory Program)
-
Ongoing clinical trials advancing PFA in VT and beyond